Ra Capital Management as of Dec. 31, 2013
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 27 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 18.7 | $160M | 6.4M | 24.99 | |
| Sangamo Biosciences (SGMO) | 13.3 | $114M | 8.2M | 13.89 | |
| Achillion Pharmaceuticals | 10.2 | $88M | 26M | 3.32 | |
| Therapeuticsmd | 7.1 | $61M | 12M | 5.21 | |
| Novavax | 6.5 | $55M | 11M | 5.12 | |
| Ophthotech | 6.0 | $52M | 1.6M | 32.35 | |
| Prothena (PRTA) | 5.1 | $44M | 1.6M | 26.52 | |
| Dynavax Technologies Corporation | 4.1 | $35M | 18M | 1.96 | |
| BioCryst Pharmaceuticals (BCRX) | 3.9 | $33M | 4.3M | 7.60 | |
| Xencor (XNCR) | 2.9 | $25M | 2.7M | 9.14 | |
| Sunesis Pharmaceuticals | 2.7 | $23M | 4.9M | 4.74 | |
| Arrowhead Research | 2.6 | $22M | 2.0M | 10.85 | |
| Derma Sciences | 2.5 | $22M | 2.0M | 10.82 | |
| Tesaro | 2.3 | $20M | 700k | 28.24 | |
| Dyax | 1.9 | $16M | 2.1M | 7.53 | |
| Ptc Therapeutics I (PTCT) | 1.5 | $13M | 752k | 16.97 | |
| Newlink Genetics Corporation | 1.3 | $11M | 500k | 22.01 | |
| Mirati Therapeutics | 1.3 | $11M | 657k | 16.63 | |
| Rockwell Medical Technologies | 1.2 | $10M | 1.0M | 10.44 | |
| Bluebird Bio (BLUE) | 1.1 | $9.8M | 467k | 20.98 | |
| Ocera Therapeutics | 1.0 | $8.6M | 662k | 12.99 | |
| Enzo Biochem (ENZ) | 0.8 | $6.6M | 2.3M | 2.92 | |
| Macrogenics (MGNX) | 0.6 | $5.5M | 199k | 27.43 | |
| pSivida | 0.6 | $4.7M | 1.2M | 3.97 | |
| Mei Pharma | 0.4 | $3.3M | 408k | 8.01 | |
| Chelsea Therapeutics International | 0.3 | $3.0M | 667k | 4.44 | |
| Coronado Biosciences Inc. Common | 0.3 | $2.6M | 1.0M | 2.63 |
